Symbols / TEST
TEST Chart
About
The fund is an actively managed exchange-traded fund (“ETF”) the management seeks (i) to generate cash distributions based on a targeted annual cash distribution level of 25%, and (ii) capital appreciation. The fund’s strategy combines (1) synthetic long exposure to the common stock of TSLA (the “Underlying Security”), and (2) the use of options strategies designed to generate premiums. The fund is non-diversified.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 57.74 | 52W Low | 46.10 |
| Beta | — | Avg Volume | 3.04K | Volume | 1.30K |
| Target Price | — | Recom | — | Prev Close | $48.61 |
| Price | $48.04 | Change | -1.17% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
- Bitcoin's Crash Is Putting Crypto Treasury Stocks To The Test - Forbes ue, 17 Feb 2026 11
- Baird initiates Grail stock coverage with Outperform on cancer test - Investing.com South Africa ue, 17 Feb 2026 13
- FDA grants breakthrough designation to rapid test for xylazine, veterinary sedative fueling overdose crisis - Medical Economics ue, 17 Feb 2026 19
- Warren Buffett’s 2013 Stock-Buying Test Is More Relevant Than Ever in 2026 - Yahoo Finance Mon, 16 Feb 2026 11
- New Keysight tool targets faster 48 Gbps graphics and AI memory tests - Stock Titan ue, 17 Feb 2026 18
- Snap Stock Slips Despite Testing New Creator Subscriptions - TipRanks ue, 17 Feb 2026 14
- Albemarle's Huge Rally Faces Key Test With Earnings Due - Investor's Business Daily Wed, 11 Feb 2026 23
- Why Aehr Test Systems Stock Soared Today - The Motley Fool Wed, 11 Feb 2026 19
- Why Aehr Test Systems Stock Soared Today - Nasdaq Wed, 11 Feb 2026 20
- REG - RNS - Test Message - TradingView ue, 17 Feb 2026 05
- Verisk faces earnings test as AI fears pressure stock - Investing.com ue, 17 Feb 2026 15
- Visa stock set for Tuesday test after 3% drop on Class B share-swap plan - TechStock² Mon, 16 Feb 2026 16
- How a noninvasive lung test eased one heavy smoker’s cancer fears - Stock Titan ue, 17 Feb 2026 13
- Coinbase Scores Q4 Miss. Here's Why Shares Are Rebounding. - Investor's Business Daily Fri, 13 Feb 2026 21
- Rocket Lab’s Hypersonic Test Push Meets Volatile Yet Undervalued Share Price - Yahoo Finance Sat, 14 Feb 2026 20
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for TEST
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|